3-arylthioindole-2-carboxamide derivatives and analogs thereof as inhibitors of casein kinase I epsilon

Details for Australian Patent Application No. 2005277460 (hide)

Owner Aventis Pharmaceuticals Inc.

Inventors Metz, William Arthur Jr.

Agent Watermark

Pub. Number AU-A-2005277460

PCT Pub. Number WO2006/023590

Priority 60/603,348 19.08.04 US

Filing date 19 August 2005

Wipo publication date 2 March 2006

International Classifications

A61K 31/404 (2006.01)

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

Event Publications

15 March 2007 PCT application entered the National Phase

  PCT publication WO2006/023590 Priority application(s): WO2006/023590

17 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005277461-Enhanced oil delivery from structured surfactant formulations

2005277459-Dialysis implant and methods of use